In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.

In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes.
Bryn Nelson, PhD |
CPPD is notoriously difficult to diagnose due to its diverse presentations & uncertain etiology. Recent advances have helped rheumatologists better understand its risk factors, classify, diagnose & treat the condition.
Clark Kent, Hannah Montana, Dexter Morgan, David Bowie and your friendly neighborhood rheumatologist: What do all of these people have in common? Chances are, they live secret lives we rarely get to peer into. Unlike Superman, Miley Stewart, Dexter Morgan and Ziggy Stardust, rheumatologists are very much real, flesh-and-blood characters. Rheumatologists also have secret lives…
Carol A. Langford, MD, MHS |
Encouraging lawmakers to pass legislation and promote policies that positively affect rheumatologists, rheumatology care teams and those living with rheumatic disease is one of the most impactful ways the ACR advances its mission. The role of advocacy has never been more critical than in recent months, when we have seen an unprecedented number of executive…
Audrey Liu, MD |
An American rheumatology fellow explores the differences& similarities between the U.S. & Chinese health systems through a visit toa hospital inHangzhou, China.
Jude Al Qaqaa, MD, Vladimir Falb, DO, & Kaitlyn Buzard, DO |
Giant cell arteritis (GCA), is an inflammatory vasculitis that involves large- and mediumsized arteries, most commonly the cranial branches of the carotid artery.1 It is seen in individuals 50 years and older.1 The most typical manifestation is new-onset headache with scalp tenderness and jaw claudication. 2 The most feared complication associated with GCA is permanent…
Jannel Lawrence, MD |
A third-year internal medicine resident describes the impact of attending ACR Convergence & the benefits of participating in the Choose Rheumatology Experience hosted by the Rheumatology Research Foundation.
Deborah Levenson |
Results of the international SELECT-GCA study suggest that upadacitinib may be an effective new oral treatment for giant cell arteritis.
An overview of highlights from the 2025 ECIM meeting, including research on treatment options for systemic sclerosis, the management of PMR & autoimmune testing.
Dr. Christopher Morris discusses his approach to training the next generation of rheumatologists to account for disparities in access to rheumatic care& the value of multidisciplinary medical organizations.
ACR Past President Douglas White, MD, PhD, discusses his transition to private practice & the tensions between private practice & academic rheumatologists.
Here is a brief recap of the latest FDA-approved biosimilar agents, highlighting their reference products and interchangeability.
Supported by data in patients with new-onset and relapsing giant cell arteritis (GCA), the FDA approved upadacitinib for the treatment of adults with GCA.